Tempo differito
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
30,66 EUR | -2,91% |
|
-2,05% | -4,03% |
13:49 | ROCHE HOLDINGS AG : valutazione poco convinta da Goldman Sachs | ZD |
13:14 | Focus sul mercato-I mercati azionari europei salgono in assenza di Wall Street | RE |
Attività
Vendite per attività
CHF in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Pharmaceuticals
76,6
%
| 48 628 | 73,2 % | 46 279 | 76,6 % | -4,83% |
Diagnostics
23,4
%
| 17 798 | 26,8 % | 14 162 | 23,4 % | -20,43% |
Vendite per regione
CHF in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
46,9
%
| 29 313 | 44,1 % | 28 352 | 46,9 % | -3,28% |
Rest of Europe
16,1
%
| 10 328 | 15,5 % | 9 703 | 16,1 % | -6,05% |
Rest of Asia
14,7
%
| 9 852 | 14,8 % | 8 890 | 14,7 % | -9,76% |
Japan
7,4
%
| 6 452 | 9,7 % | 4 464 | 7,4 % | -30,81% |
Latin America
4,9
%
| 2 870 | 4,3 % | 2 971 | 4,9 % | +3,52% |
Germany
4,8
%
| 3 318 | 5,0 % | 2 893 | 4,8 % | -12,81% |
Africa, Australia and Oceania
2,0
%
| 1 520 | 2,3 % | 1 212 | 2,0 % | -20,26% |
Switzerland
1,8
%
| 1 671 | 2,5 % | 1 118 | 1,8 % | -33,09% |
Rest of North America
1,4
%
| 1 102 | 1,7 % | 838 | 1,4 % | -23,96% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Chief Executive Officer | 49 | 01/01/03 | |
Severin Schwan
CHM | Chairman | 57 | 01/01/08 |
Alan Hippe
DFI | Director of Finance/CFO | 57 | 01/04/11 |
Pascale Schmidt
CMP | Compliance Officer | 51 | 01/01/20 |
Levi Garraway
CTO | Chief Tech/Sci/R&D Officer | - | - |
Bruno Eschli
IRC | Investor Relations Contact | - | - |
Silke Hörnstein
PRN | Corporate Officer/Principal | 49 | 01/01/15 |
Annette Luther
SEC | Corporate Secretary | 54 | 01/04/20 |
General Counsel | 60 | 01/04/20 | |
Human Resources Officer | 57 | - |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Bernard Poussot
BRD | Director/Board Member | 72 | 03/03/15 |
Director/Board Member | 59 | - | |
Director/Board Member | 66 | 01/01/96 | |
Patrick Frost
BRD | Director/Board Member | 56 | 17/03/20 |
Hans Clevers
PRN | Corporate Officer/Principal | 67 | 05/03/19 |
Severin Schwan
CHM | Chairman | 57 | 01/01/08 |
Anita Hauser
BRD | Director/Board Member | 55 | 14/03/17 |
Director/Board Member | 58 | 01/03/16 | |
Jemilah Mahmood
BRD | Director/Board Member | - | - |
Akiko Iwasaki
BRD | Director/Board Member | - | - |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 106 691 000 | 28 989 189 ( 27,17 %) | 0 | 88,91 % |
Azione B | 1 | 702 562 700 | 690 549 674 ( 98,29 %) | 12 011 755 ( 1,710 %) |
Partecipazioni
Nome | Azioni | % | Valorizzazione |
---|---|---|---|
1 005 670 000 | 59.89% | 30 596 634 817 $ | |
ROCHE HOLDING AG 1.43% | 10 073 029 | 1.43% | 2 579 249 239 $ |
2 744 120 | 7.42% | 42 451 536 $ | |
454 961 | 3.02% | 11 810 788 $ | |
ALIGOS THERAPEUTICS, INC. 14.70% | 11 025 941 | 14.70% | 6 505 305 $ |
1 893 | 0.06% | 1 609 $ |
Coordinate società
![Indirizzo Roche Holding AG(RHO6)](https://cdn.zonebourse.com/static/address/50913575.png)
Società del gruppo
Nome | Categoria e settore |
---|---|
Viewics India Pvt Ltd.
| |
Roche Financial Investments Ltd.
| |
Roche Diagnostics Belgium NV
![]() Roche Diagnostics Belgium NV BiotechnologyHealth Technology Part of Roche Holding AG, Roche Diagnostics Belgium NV is a Belgian company that develops innovative products and services for the prevention, diagnosis, monitoring, screening, and treatment of diseases. Roche Diagnostics Belgium is based in Diegem, Belgium, and was founded in 1958. The company offers next-generation sequencing products and in vitro diagnostics that are an integral part of decision-making along the entire continuum of a patient's health or disease. The CEO is Thomas Schinecker. |
Biotechnology
|
Roche Finance Europe BV
|
Finance/Rental/Leasing
|
Roche Financial Management Ltd.
| |
Roche Catalyst Investments Ltd.
| |
Roche Intertrade Ltd.
| |
Roche Pharmholding BV
![]() Roche Pharmholding BV Medical DistributorsDistribution Services Part of Roche Holding AG, Roche Pharmholding BV is a Dutch company that manufactures and distributes pharmaceutical and vitamin products. The company is based in Woerden, Netherlands. |
Medical Distributors
|
Sapac Corp. Ltd.
|
Settore
Vendite per attività
Vendite per regione
![Consenso](/images/consensus_flch.gif)
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
+54,07% | 809 Mrd | |
+39,75% | 621 Mrd | |
-7,05% | 351 Mrd | |
+15,44% | 319 Mrd | |
+5,72% | 289 Mrd | |
+14,70% | 238 Mrd | |
+14,48% | 218 Mrd | |
+7,42% | 166 Mrd | |
-3,79% | 157 Mrd |
- Borsa valori
- Azioni
- Azione ROG
- Azione RHO6
- Società Roche Holding AG